B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis

Anqi Lin,1,* Jianbo Fang,1,* Quan Cheng,2,3 Zaoqu Liu,4 Peng Luo,1 Jian Zhang1 1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People’s Republic of China; 2Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan,...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lin A, Fang J, Cheng Q, Liu Z, Luo P, Zhang J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2022-09-01
Colecção:	Journal of Inflammation Research
Assuntos:	non-small cell lung cancer b cell receptor immune checkpoint inhibitor biomarker microenvironment.
Acesso em linha:	https://www.dovepress.com/b-cell-receptor-signaling-pathway-mutation-as-prognosis-predictor-of-i-peer-reviewed-fulltext-article-JIR
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!